Predictive value of control of COPD for risk of exacerbations: An international, prospective study
- PMID: 32249487
- DOI: 10.1111/resp.13811
Predictive value of control of COPD for risk of exacerbations: An international, prospective study
Abstract
Background and objective: The concept of clinical control in COPD has been developed to help in treatment decisions, but it requires validation in prospective studies.
Methods: This international, multicentre, prospective study aimed to validate the concept of control in COPD. Patients with COPD were classified as controlled/uncontrolled by clinical criteria or CAT scores at baseline and followed up for 18 months. The main outcome was the difference in rate of a composite endpoint of moderate and severe exacerbations or death over the 18-month follow-up period.
Results: A total of 307 patients were analysed (mean age = 68.6 years and mean FEV1 % = 52.5%). Up to 65% and 37.9% of patients were classified as controlled by clinical criteria or CAT, respectively. Controlled patients had significantly less exacerbations during follow-up (by clinical criteria: 1.1 vs 2.6, P < 0.001; by CAT: 1.1 vs 1.9, P = 0.014). Time to first exacerbation was significantly prolonged for patients controlled by clinical criteria only (median: 93 days, IQR: 63; 242 vs 274 days, IQR: 221; 497 days; P < 0.001). Control status by clinical criteria was a better predictor of exacerbations compared to CAT criteria (AUC: 0.67 vs 0.57).
Conclusion: Control status, defined by easy-to-obtain clinical criteria, is predictive of future exacerbation risk and time to the next exacerbation. The concept of control can be used in clinical practice at each clinical visit as a complement to the current recommendations of initial treatment proposed by guidelines.
Keywords: Chronic Obstructive Pulmonary Disease Assessment Test; clinical control status; dyspnoea; exacerbations; prevention.
© 2020 Asian Pacific Society of Respirology.
Comment in
-
Bringing COPD control into the consultation.Respirology. 2020 Nov;25(11):1110-1111. doi: 10.1111/resp.13884. Epub 2020 Jul 12. Respirology. 2020. PMID: 32656963 No abstract available.
References
REFERENCES
-
- Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 report: GOLD executive summary. Respirology 2017; 22: 575-601.
-
- Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Riesco JA et al. Spanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary disease. Arch. Bronconeumol. 2017; 53: 324-35.
-
- Soler-Cataluña JJ, Alcazar-Navarrete B, Miravitlles M. The concept of control in COPD: a new proposal for optimising therapy. Eur. Respir. J. 2014; 44: 1072-5.
-
- Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur. Respir. J. 2019; 53: pii 1900164.
-
- Soler-Cataluña JJ, Alcazar B, Miravitlles M. The concept of control of COPD in clinical practice. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 1397-405.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
